PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9250823-2 1997 Exposure of Farage cells, derived from a human B-cell lymphoma, to phorbol 12-myristate 13-acetate (PMA) down-regulated CD21 and CD23 expression, while interleukin 4 (IL4) inhibited the expression of CD21 but augmented CD23 expression. Tetradecanoylphorbol Acetate 67-98 Fc epsilon receptor II Homo sapiens 129-133 9420139-0 1997 A new role for interleukin-7 in the induction of LFA-1 and VLA-4 adhesion molecules in Phorbol 12myristate 13acetate activated CD4+ CD23+ T-cell subset. Tetradecanoylphorbol Acetate 87-116 Fc epsilon receptor II Homo sapiens 132-136 9395008-1 1997 The purpose of this study is to elucidate the effect of interleukin-7 (IL-7) and soluble CD23 (sCD23) on Phorbol12 Myristate13 Acetate (PMA) activated CD4+ TCR alpha beta+ cells of HIV-1 infected subjects. Tetradecanoylphorbol Acetate 105-134 Fc epsilon receptor II Homo sapiens 89-93 9395008-1 1997 The purpose of this study is to elucidate the effect of interleukin-7 (IL-7) and soluble CD23 (sCD23) on Phorbol12 Myristate13 Acetate (PMA) activated CD4+ TCR alpha beta+ cells of HIV-1 infected subjects. Tetradecanoylphorbol Acetate 136-139 Fc epsilon receptor II Homo sapiens 89-93 9420139-3 1997 METHODS AND RESULTS: We studied the effect of interleukin 7 (IL-7) on the expression of CD23 in normal PBT cells stimulated with PMA + Ca2. Tetradecanoylphorbol Acetate 129-132 Fc epsilon receptor II Homo sapiens 88-92 9250823-2 1997 Exposure of Farage cells, derived from a human B-cell lymphoma, to phorbol 12-myristate 13-acetate (PMA) down-regulated CD21 and CD23 expression, while interleukin 4 (IL4) inhibited the expression of CD21 but augmented CD23 expression. Tetradecanoylphorbol Acetate 67-98 Fc epsilon receptor II Homo sapiens 219-223 9250823-2 1997 Exposure of Farage cells, derived from a human B-cell lymphoma, to phorbol 12-myristate 13-acetate (PMA) down-regulated CD21 and CD23 expression, while interleukin 4 (IL4) inhibited the expression of CD21 but augmented CD23 expression. Tetradecanoylphorbol Acetate 100-103 Fc epsilon receptor II Homo sapiens 129-133 9250823-2 1997 Exposure of Farage cells, derived from a human B-cell lymphoma, to phorbol 12-myristate 13-acetate (PMA) down-regulated CD21 and CD23 expression, while interleukin 4 (IL4) inhibited the expression of CD21 but augmented CD23 expression. Tetradecanoylphorbol Acetate 100-103 Fc epsilon receptor II Homo sapiens 219-223 8657015-0 1995 Expression of 18.6/CD23 antigen on human lymphoid progenitor cell lines and phorbol 12-myristate 13-acetate (PMA)-induced microglia-shaped cells. Tetradecanoylphorbol Acetate 76-107 Fc epsilon receptor II Homo sapiens 19-31 8938103-4 1996 The results demonstrate that cytoplasmic CD23 level was significantly augmented by costimulation with PMA + Ca2 plus IL-7 (1000 U/ml). Tetradecanoylphorbol Acetate 102-105 Fc epsilon receptor II Homo sapiens 41-45 7873388-5 1995 In contrast, phorbol esters (PMA) up-regulate both CD23 isoforms in the malignant B cells and specifically increases type B in normal B cells. Tetradecanoylphorbol Acetate 29-32 Fc epsilon receptor II Homo sapiens 51-55 8242759-1 1993 The expression of CD23 on human tonsillar B cells is increased following treatment with interleukin 4 (IL-4) or 12-O-tetradecanoylphorbol 13-acetate (TPA), while that of surface immunoglobulins (sIgs) is increased by IL-4 but decreased by TPA. Tetradecanoylphorbol Acetate 112-148 Fc epsilon receptor II Homo sapiens 18-22 8242759-1 1993 The expression of CD23 on human tonsillar B cells is increased following treatment with interleukin 4 (IL-4) or 12-O-tetradecanoylphorbol 13-acetate (TPA), while that of surface immunoglobulins (sIgs) is increased by IL-4 but decreased by TPA. Tetradecanoylphorbol Acetate 150-153 Fc epsilon receptor II Homo sapiens 18-22 8242759-1 1993 The expression of CD23 on human tonsillar B cells is increased following treatment with interleukin 4 (IL-4) or 12-O-tetradecanoylphorbol 13-acetate (TPA), while that of surface immunoglobulins (sIgs) is increased by IL-4 but decreased by TPA. Tetradecanoylphorbol Acetate 239-242 Fc epsilon receptor II Homo sapiens 18-22 8242759-7 1993 In comparison, the up-regulation of CD23 by IL-4 and TPA was only partially blocked by these PKC inhibitors. Tetradecanoylphorbol Acetate 53-56 Fc epsilon receptor II Homo sapiens 36-40 8242759-8 1993 TK inhibitors, such as herbimycin A and genistein, decreased both the IL-4- and TPA-induced CD23 expression by 50-80%, but had modest effects on sIgs expression. Tetradecanoylphorbol Acetate 80-83 Fc epsilon receptor II Homo sapiens 92-96 2151634-1 1990 The expression of the low-affinity receptor for IgE Fc epsilon RII) in the human monocyte-like U-937 cell line can be upregulated by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) and by IgE. Tetradecanoylphorbol Acetate 151-187 Fc epsilon receptor II Homo sapiens 52-66 8425225-4 1993 PKC activators (PMA, diacylglycerol, indolactam) were effective inducers of CD23 gene expression, whereas calcium ionophores were not. Tetradecanoylphorbol Acetate 16-19 Fc epsilon receptor II Homo sapiens 76-80 8499771-0 1993 CD23/Fc epsilon RII expression on phytohemagglutinin-A- or phorbol-12myristate-13acetate-Ca(2+)-activated human tonsil T cells. Tetradecanoylphorbol Acetate 59-88 Fc epsilon receptor II Homo sapiens 0-4 8499771-0 1993 CD23/Fc epsilon RII expression on phytohemagglutinin-A- or phorbol-12myristate-13acetate-Ca(2+)-activated human tonsil T cells. Tetradecanoylphorbol Acetate 59-88 Fc epsilon receptor II Homo sapiens 5-19 1709049-2 1991 However, whereas CD23 expression is increased by several B cell mitogens, including phorbol 12-myristate 13-acetate, Epstein-Barr virus, anti-immunoglobulin (Ig), and IL-4, surface IgM (sIgM) expression is increased only with IL-4, suggesting that expression of each surface antigen is regulated independently. Tetradecanoylphorbol Acetate 84-115 Fc epsilon receptor II Homo sapiens 17-21 2151634-1 1990 The expression of the low-affinity receptor for IgE Fc epsilon RII) in the human monocyte-like U-937 cell line can be upregulated by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) and by IgE. Tetradecanoylphorbol Acetate 189-192 Fc epsilon receptor II Homo sapiens 52-66 2151634-2 1990 TPA induces terminal differentiation of U-937 cells and causes a four- to fivefold increase in the number of Fc epsilon RII. Tetradecanoylphorbol Acetate 0-3 Fc epsilon receptor II Homo sapiens 109-123 2151634-4 1990 IgE alone has a modest effect on the expression of Fc epsilon RII (about a 10% increase), while simultaneous treatment of U-937 cells with TPA and IgE has a cooperative effect, causing an eightfold increase in the number of Fc epsilon RII. Tetradecanoylphorbol Acetate 139-142 Fc epsilon receptor II Homo sapiens 51-65 2151634-4 1990 IgE alone has a modest effect on the expression of Fc epsilon RII (about a 10% increase), while simultaneous treatment of U-937 cells with TPA and IgE has a cooperative effect, causing an eightfold increase in the number of Fc epsilon RII. Tetradecanoylphorbol Acetate 139-142 Fc epsilon receptor II Homo sapiens 224-238 2151634-5 1990 Cycloheximide strongly suppresses the expression of Fc epsilon RII, both in TPA-stimulated and unstimulated cells; this effect can be partly reversed by culturing the cells in the presence of IgE. Tetradecanoylphorbol Acetate 76-79 Fc epsilon receptor II Homo sapiens 52-66 2522048-1 1989 We have found that approximately 10%-15% of tonsil, but not peripheral blood, T cells express the CD23 antigen following activation with 12-O-tetradecanoylphorbol 13-acetate (TPA), phytohemagglutinin (PHA) or recombinant interleukin 4. Tetradecanoylphorbol Acetate 137-173 Fc epsilon receptor II Homo sapiens 98-102 2522048-6 1989 Similarly, SN from a CD23+ L cell transfectant augments the proliferative response of tonsil T cells to both TPA and PHA. Tetradecanoylphorbol Acetate 109-112 Fc epsilon receptor II Homo sapiens 21-25 2522048-7 1989 The CD23 molecule expressed by TPA-driven T cell blasts appears identical in size to the 45-kDa glycoprotein present on EBVLCL and activated B cells. Tetradecanoylphorbol Acetate 31-34 Fc epsilon receptor II Homo sapiens 4-8 2522048-9 1989 The results presented here demonstrate that CD23 is expressed on activated tonsil, but not peripheral blood T cells and plays a role, via the binding of CD23 mAb and CD23+ material, present in EBVLCL and CD23+ transfectant SN, in the regulation of T cell proliferation in response to mitogens such as PHA and TPA. Tetradecanoylphorbol Acetate 309-312 Fc epsilon receptor II Homo sapiens 44-48 2522048-9 1989 The results presented here demonstrate that CD23 is expressed on activated tonsil, but not peripheral blood T cells and plays a role, via the binding of CD23 mAb and CD23+ material, present in EBVLCL and CD23+ transfectant SN, in the regulation of T cell proliferation in response to mitogens such as PHA and TPA. Tetradecanoylphorbol Acetate 309-312 Fc epsilon receptor II Homo sapiens 153-157 2522048-9 1989 The results presented here demonstrate that CD23 is expressed on activated tonsil, but not peripheral blood T cells and plays a role, via the binding of CD23 mAb and CD23+ material, present in EBVLCL and CD23+ transfectant SN, in the regulation of T cell proliferation in response to mitogens such as PHA and TPA. Tetradecanoylphorbol Acetate 309-312 Fc epsilon receptor II Homo sapiens 153-157 2522048-9 1989 The results presented here demonstrate that CD23 is expressed on activated tonsil, but not peripheral blood T cells and plays a role, via the binding of CD23 mAb and CD23+ material, present in EBVLCL and CD23+ transfectant SN, in the regulation of T cell proliferation in response to mitogens such as PHA and TPA. Tetradecanoylphorbol Acetate 309-312 Fc epsilon receptor II Homo sapiens 153-157 2522048-1 1989 We have found that approximately 10%-15% of tonsil, but not peripheral blood, T cells express the CD23 antigen following activation with 12-O-tetradecanoylphorbol 13-acetate (TPA), phytohemagglutinin (PHA) or recombinant interleukin 4. Tetradecanoylphorbol Acetate 175-178 Fc epsilon receptor II Homo sapiens 98-102 29763855-6 2018 Moreover, we have experimentally stimulated the CD23 phosphorylations in a subset of peripheral blood lymphocytes of healthy controls by phorbol-12-myristate-13-acetate treatment. Tetradecanoylphorbol Acetate 137-168 Fc epsilon receptor II Homo sapiens 48-52 2957693-3 1987 While the activation of purified quiescent B cells with phorbol 12-myristate 13-acetate led to the induction of 45-kDa CD23 at the surface membrane, the inclusion of IgE increased CD23 expression by a factor of approximately equal to 5. Tetradecanoylphorbol Acetate 56-87 Fc epsilon receptor II Homo sapiens 119-123